WallStreetZenWallStreetZen

NASDAQ: JAGX
Jaguar Health Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

JAGX past revenue growth

How has JAGX's revenue growth performed historically?
Company
-18.36%
Industry
145.73%
Market
17.2%
JAGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
JAGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
JAGX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

JAGX earnings and revenue history

Current Revenue
$9.8M
Current Earnings
-$41.3M
Current Profit Margin
-423.1%

JAGX Return on Equity

Current Company
-855.6%
Current Industry
-63.5%
Current Market
188%
JAGX's Return on Equity (-855.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when JAGX announces earnings.

JAGX Return on Assets

Current Company
-80.5%
Current Industry
2.9%
JAGX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

JAGX Return on Capital Employed

Current Company
-94.95%
Current Industry
19.5%
JAGX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JAGX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
JAGX$9.76M-$32.53M-$41.30M+17.19%N/A
NKGN$0.00-$80.64M-$82.95M-100.00%N/A
INAB$0.00-$27.51M-$30.01MN/AN/A
QNCX$0.00-$31.26M-$31.39MN/AN/A
CLNN$654.00k-$42.81M-$49.50M+129.56%N/A
View Top Biotech Stocks

JAGX earnings dates

Next earnings date
May 13, 2024

Jaguar Health Earnings & Revenue FAQ

What were JAGX's earnings last quarter?

On Invalid Date, Jaguar Health (NASDAQ: JAGX) reported Q4 2023 earnings per share (EPS) of $0.42, up 4.55% year over year. Total Jaguar Health earnings for the quarter were -$9.17 million. In the same quarter last year, Jaguar Health's earnings per share (EPS) was $0.44.

If you're new to stock investing, here's how to buy Jaguar Health stock.

What was JAGX's earnings growth in the past year?

As of Q2 2024, Jaguar Health's earnings has grown year over year. Jaguar Health's earnings in the past year totalled -$41.30 million.

What is JAGX's earnings date?

Jaguar Health's earnings date is Invalid Date. Add JAGX to your watchlist to be reminded of JAGX's next earnings announcement.

What was JAGX's revenue last quarter?

On Invalid Date, Jaguar Health (NASDAQ: JAGX) reported Q4 2023 revenue of $2.30 million up 29.45% year over year. In the same quarter last year, Jaguar Health's revenue was $3.26 million.

What was JAGX's revenue growth in the past year?

As of Q2 2024, Jaguar Health's revenue has grown -18.36% year over year. This is 164.09 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Jaguar Health's revenue in the past year totalled $9.76 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.